Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed) (PAR-23-237)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed) (RFA-AG-24-046)

Sponsor: National Institute on Aging

Due Date: February 07, 2024

Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed) • (RFA-AG-24-027)

Sponsor: National Institute on Aging

Due Date: February 14, 2024

Notice of Participation of NIA in PAR-23-220, "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)" (NOT-AG-23-048)

Sponsor: National Institute on Aging

Health Equity and the Cost of Novel Treatments for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed) (RFA-AG-24-050)

Sponsor: National Institute on Aging

Due Date: LOI due September 29, 2023. Application due October 31, 2023.

NIH Blueprint and BRAIN Initiative Program for Enhancing Neuroscience Diversity through Undergraduate Research Education Experiences (BP BRAIN-ENDURE) (R25 Clinical Trial Not Allowed) (RFA-NS-24-014)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Notice of Special Interest: Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity (Admin Supp) (NOT-NS-23-092)

Sponsor: National Institutes of Health

NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) (PAR-23-178)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) (RFA-MH-24-280)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional) (RFA-HG-23-017)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional) (RFA-HG-23-018)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (UT1/UT2) Clinical Trial Not Allowed (PAR-23-268)

Sponsor: National Center for Advancing Translational Sciences

Due Date: Multiple due dates; see announcement. LOI due 30 days before application.

Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed) (PAR-23-267)

Sponsor: National Center for Advancing Translational Sciences

Due Date: Multiple due dates; see announcement. LOI due 30 days before application.

BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Required) (RFA-MH-23-330)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed) (RFA-MH-23-331)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.